REPORT ID 13849

EMEA (Europe, Middle East and Africa) Plasma Fractionation Market Report 2017

Publish Date
22-Nov-17
Pages
101
Format
Electronic (PDF)

In this report, the EMEA Plasma Fractionation market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Plasma Fractionation for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Plasma Fractionation market competition by top manufacturers/players, with Plasma Fractionation sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Shire
    CSL
    Grifols
    Octapharma
    BPL
    Kedrion
    Mitsubishi Tanabe
    CBOP
    RAAS
    Hualan Bio

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Albumin
    Immune Globulin
    Coagulation Factor

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Plasma Fractionation for each application, including
    Immunity
    Therapy
    Surgery
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Plasma Fractionation Market Report 2017
1 Plasma Fractionation Overview
    1.1 Product Overview and Scope of Plasma Fractionation
    1.2 Classification of Plasma Fractionation
        1.2.1 EMEA Plasma Fractionation Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Plasma Fractionation Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Albumin
        1.2.4 Immune Globulin
        1.2.5 Coagulation Factor
    1.3 EMEA Plasma Fractionation Market by Application/End Users
        1.3.1 EMEA Plasma Fractionation Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Immunity
        1.3.3 Therapy
        1.3.4 Surgery
        1.3.5 Other
    1.4 EMEA Plasma Fractionation Market by Region
        1.4.1 EMEA Plasma Fractionation Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Plasma Fractionation (2012-2022)
        1.5.1 EMEA Plasma Fractionation Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Plasma Fractionation Revenue and Growth Rate (2012-2022)

2 EMEA Plasma Fractionation Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Plasma Fractionation Market Competition by Players/Manufacturers
        2.1.1 EMEA Plasma Fractionation Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Plasma Fractionation Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Plasma Fractionation Sale Price by Players (2012-2017)
    2.2 EMEA Plasma Fractionation (Volume and Value) by Type/Product Category
        2.2.1 EMEA Plasma Fractionation Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Plasma Fractionation Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Plasma Fractionation Sale Price by Type (2012-2017)
    2.3 EMEA Plasma Fractionation (Volume) by Application
    2.4 EMEA Plasma Fractionation (Volume and Value) by Region
        2.4.1 EMEA Plasma Fractionation Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Plasma Fractionation Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Plasma Fractionation Sales Price by Region (2012-2017)

3 Europe Plasma Fractionation (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Plasma Fractionation Sales and Value (2012-2017)
        3.1.1 Europe Plasma Fractionation Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Plasma Fractionation Revenue and Growth Rate (2012-2017)
    3.2 Europe Plasma Fractionation Sales and Market Share by Type
    3.3 Europe Plasma Fractionation Sales and Market Share by Application
    3.4 Europe Plasma Fractionation Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Plasma Fractionation Sales Volume by Countries (2012-2017)
        3.4.2 Europe Plasma Fractionation Revenue by Countries (2012-2017)
        3.4.3 Germany Plasma Fractionation Sales and Growth Rate (2012-2017)
        3.4.4 France Plasma Fractionation Sales and Growth Rate (2012-2017)
        3.4.5 UK Plasma Fractionation Sales and Growth Rate (2012-2017)
        3.4.6 Russia Plasma Fractionation Sales and Growth Rate (2012-2017)
        3.4.7 Italy Plasma Fractionation Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Plasma Fractionation Sales and Growth Rate (2012-2017)

4 Middle East Plasma Fractionation (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Plasma Fractionation Sales and Value (2012-2017)
        4.1.1 Middle East Plasma Fractionation Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Plasma Fractionation Revenue and Growth Rate (2012-2017)
    4.2 Middle East Plasma Fractionation Sales and Market Share by Type
    4.3 Middle East Plasma Fractionation Sales and Market Share by Application
    4.4 Middle East Plasma Fractionation Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Plasma Fractionation Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Plasma Fractionation Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Plasma Fractionation Sales and Growth Rate (2012-2017)
        4.4.4 Israel Plasma Fractionation Sales and Growth Rate (2012-2017)
        4.4.5 UAE Plasma Fractionation Sales and Growth Rate (2012-2017)
        4.4.6 Iran Plasma Fractionation Sales and Growth Rate (2012-2017)

5 Africa Plasma Fractionation (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Plasma Fractionation Sales and Value (2012-2017)
        5.1.1 Africa Plasma Fractionation Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Plasma Fractionation Revenue and Growth Rate (2012-2017)
    5.2 Africa Plasma Fractionation Sales and Market Share by Type
    5.3 Africa Plasma Fractionation Sales and Market Share by Application
    5.4 Africa Plasma Fractionation Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Plasma Fractionation Sales Volume by Countries (2012-2017)
        5.4.2 Africa Plasma Fractionation Revenue by Countries (2012-2017)
        5.4.3 South Africa Plasma Fractionation Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Plasma Fractionation Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Plasma Fractionation Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Plasma Fractionation Sales and Growth Rate (2012-2017)

6 EMEA Plasma Fractionation Manufacturers/Players Profiles and Sales Data
    6.1 Shire
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Plasma Fractionation Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Shire Plasma Fractionation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 CSL
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Plasma Fractionation Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 CSL Plasma Fractionation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Grifols
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Plasma Fractionation Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Grifols Plasma Fractionation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Octapharma
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Plasma Fractionation Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Octapharma Plasma Fractionation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 BPL
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Plasma Fractionation Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 BPL Plasma Fractionation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Kedrion
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Plasma Fractionation Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Kedrion Plasma Fractionation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Mitsubishi Tanabe
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Plasma Fractionation Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Mitsubishi Tanabe Plasma Fractionation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 CBOP
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Plasma Fractionation Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 CBOP Plasma Fractionation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 RAAS
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Plasma Fractionation Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 RAAS Plasma Fractionation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Hualan Bio
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Plasma Fractionation Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Hualan Bio Plasma Fractionation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview

7 Plasma Fractionation Manufacturing Cost Analysis
    7.1 Plasma Fractionation Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Plasma Fractionation

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Plasma Fractionation Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Plasma Fractionation Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Plasma Fractionation Market Forecast (2017-2022)
    11.1 EMEA Plasma Fractionation Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Plasma Fractionation Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Plasma Fractionation Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Plasma Fractionation Price and Trend Forecast (2017-2022)
    11.2 EMEA Plasma Fractionation Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Plasma Fractionation Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Plasma Fractionation Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Plasma Fractionation Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Plasma Fractionation Sales Forecast by Type (2017-2022)
    11.7 EMEA Plasma Fractionation Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer